249 related articles for article (PubMed ID: 22160875)
1. Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis.
Azhdarinia A; Ghosh P; Ghosh S; Wilganowski N; Sevick-Muraca EM
Mol Imaging Biol; 2012 Jun; 14(3):261-76. PubMed ID: 22160875
[TBL] [Abstract][Full Text] [Related]
2. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
[TBL] [Abstract][Full Text] [Related]
3. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
[TBL] [Abstract][Full Text] [Related]
4. Quicker, deeper and stronger imaging: A review of tumor-targeted, near-infrared fluorescent dyes for fluorescence guided surgery in the preclinical and clinical stages.
Jiao J; Zhang J; Yang F; Song W; Han D; Wen W; Qin W
Eur J Pharm Biopharm; 2020 Jul; 152():123-143. PubMed ID: 32437752
[TBL] [Abstract][Full Text] [Related]
5. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
[TBL] [Abstract][Full Text] [Related]
6. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
7. A Conjugate of Pentamethine Cyanine and
An FF; Kommidi H; Chen N; Ting R
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590411
[TBL] [Abstract][Full Text] [Related]
8. In vivo near-infrared fluorescence imaging of cancer with nanoparticle-based probes.
He X; Wang K; Cheng Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):349-66. PubMed ID: 20564463
[TBL] [Abstract][Full Text] [Related]
9. Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography.
Dullin C; Zientkowska M; Napp J; Missbach-Guentner J; Krell HW; Müller F; Grabbe E; Tietze LF; Alves F
Mol Imaging; 2009; 8(1):2-14. PubMed ID: 19344571
[TBL] [Abstract][Full Text] [Related]
10. A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects.
Kimura RH; Miao Z; Cheng Z; Gambhir SS; Cochran JR
Bioconjug Chem; 2010 Mar; 21(3):436-44. PubMed ID: 20131753
[TBL] [Abstract][Full Text] [Related]
11. Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.
Lütje S; Rijpkema M; Helfrich W; Oyen WJ; Boerman OC
Mol Imaging Biol; 2014 Dec; 16(6):747-55. PubMed ID: 24849133
[TBL] [Abstract][Full Text] [Related]
12. Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation.
Kim JS; Kim YH; Kim JH; Kang KW; Tae EL; Youn H; Kim D; Kim SK; Kwon JT; Cho MH; Lee YS; Jeong JM; Chung JK; Lee DS
Nanomedicine (Lond); 2012 Feb; 7(2):219-29. PubMed ID: 22175235
[TBL] [Abstract][Full Text] [Related]
13. Structurally symmetric near-infrared fluorophore IRDye78-protein complex enables multimodal cancer imaging.
Yang J; Zhao C; Lim J; Zhao L; Tourneau RL; Zhang Q; Dobson D; Joshi S; Pang J; Zhang X; Pal S; Andreou C; Zhang H; Kircher MF; Schmitthenner H
Theranostics; 2021; 11(6):2534-2549. PubMed ID: 33456558
[No Abstract] [Full Text] [Related]
14. Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging.
Ughi GJ; Verjans J; Fard AM; Wang H; Osborn E; Hara T; Mauskapf A; Jaffer FA; Tearney GJ
Int J Cardiovasc Imaging; 2015 Feb; 31(2):259-68. PubMed ID: 25341407
[TBL] [Abstract][Full Text] [Related]
15. Nuclear and optical dual-labelled imaging agents. Design and challenges.
Singh G; Gott MD; Pietzsch HJ; Stephan H
Nuklearmedizin; 2016; 55(2):41-50. PubMed ID: 27067792
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive near-infrared imaging of fluorochromes within the brain of live mice: an in vivo phantom study.
Klohs J; Steinbrink J; Nierhaus T; Bourayou R; Lindauer U; Bahmani P; Dirnagl U; Wunder A
Mol Imaging; 2006 Jul; 5(3):180-7. PubMed ID: 16954033
[TBL] [Abstract][Full Text] [Related]
17. Advances in the Development of Multimodal Imaging Agents for Nuclear/Near-infrared Fluorescence Imaging.
Ghosh SC; Azhdarinia A
Curr Med Chem; 2015; 22(29):3390-404. PubMed ID: 26337105
[TBL] [Abstract][Full Text] [Related]
18. Lipophilic Near-Infrared Dyes for In Vivo Fluorescent Cell Tracking.
Basel MT
Methods Mol Biol; 2020; 2126():33-43. PubMed ID: 32112377
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.
Hara T; Bhayana B; Thompson B; Kessinger CW; Khatri A; McCarthy JR; Weissleder R; Lin CP; Tearney GJ; Jaffer FA
JACC Cardiovasc Imaging; 2012 Jun; 5(6):607-15. PubMed ID: 22698530
[TBL] [Abstract][Full Text] [Related]
20. A review of NIR dyes in cancer targeting and imaging.
Luo S; Zhang E; Su Y; Cheng T; Shi C
Biomaterials; 2011 Oct; 32(29):7127-38. PubMed ID: 21724249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
